Nat Arlander

Nat Arlander is a strategic leader in the biotech sector, currently serving as the Senior Director and Head of the Plasma Innovation Hub at Takeda, where they focus on disruptive innovation. With over 15 years of experience, Nat has held numerous leadership roles across engineering, R&D, corporate strategy, and operations, significantly contributing to the development of innovative therapies. They have achieved notable successes, including formulating a $5 billion revenue strategy for Plasma Derived Therapies and leading initiatives that saved thousands of FTE hours at Shire. Nat's dedication to improving patient outcomes is driven by a personal commitment to addressing the needs of those with rare diseases.